Amgen Inc. buy BMO Capital Markets
Start price
03.12.25
/
50%
€288.65
Target price
03.12.26
-
Performance (%)
-6.96%
Price
08:28
€268.55
Summary
This prediction is currently active. With a performance of -6.96%, the BUY prediction by BMO_Capital_Markets is trending in the wrong direction. This prediction currently runs until 03.12.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Amgen Inc. | -6.96% |
| iShares Core DAX® | 1.659% |
| iShares Nasdaq 100 | 0.381% |
| iShares Nikkei 225® | 2.102% |
| iShares S&P 500 | 0.221% |
Comments by BMO_Capital_Markets for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Ratings data for AMGN provided by MarketBeat